Cargando…

Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells

BACKGROUND: Liver cancer stem cells (LCSCs) are a small subset of cells characterized by unlimited self-renewal, cell differentiation, and uncontrollable cellular growth. LCSCs are also resistant to conventional therapies and are thus believed to be held responsible for causing treatment failure of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dong-Mei, Zheng, Zi-Hui, Zhang, Ying-Bo, Fan, Shao-Hua, Zhang, Zi-Feng, Wang, Yong-Jian, Zheng, Yuan-Lin, Lu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554918/
https://www.ncbi.nlm.nih.gov/pubmed/31171015
http://dx.doi.org/10.1186/s13046-019-1239-3
_version_ 1783425050176651264
author Wu, Dong-Mei
Zheng, Zi-Hui
Zhang, Ying-Bo
Fan, Shao-Hua
Zhang, Zi-Feng
Wang, Yong-Jian
Zheng, Yuan-Lin
Lu, Jun
author_facet Wu, Dong-Mei
Zheng, Zi-Hui
Zhang, Ying-Bo
Fan, Shao-Hua
Zhang, Zi-Feng
Wang, Yong-Jian
Zheng, Yuan-Lin
Lu, Jun
author_sort Wu, Dong-Mei
collection PubMed
description BACKGROUND: Liver cancer stem cells (LCSCs) are a small subset of cells characterized by unlimited self-renewal, cell differentiation, and uncontrollable cellular growth. LCSCs are also resistant to conventional therapies and are thus believed to be held responsible for causing treatment failure of hepatocellular carcinoma (HCC). It has been recently found that long non-coding RNAs (lncRNAs) are important regulators in HCC. This present study aims to explore the underlying mechanism of how lncRNA DLX6-AS1 influences the development of LCSCs and HCC. METHODS: A microarray-based analysis was performed to initially screen differentially expressed lncRNAs associated with HCC. We then analyzed the lncRNA DLX6-AS1 levels as well as CADM1 promoter methylation. The mRNA and protein expression of CADM1, STAT3, CD133, CD13, OCT-4, SOX2, and Nanog were then detected. We quantified our results by evaluating the spheroid formation, proliferation, and tumor formation abilities, as well as the proportion of tumor stem cells, and the recruitment of DNA methyltransferase (DNMT) in LCSCs when lncRNA DLX6-AS1 was either overexpressed or silenced. RESULTS: LncRNA DLX6-AS1 was upregulated in HCC. The silencing of lncRNA DLX6-AS1 was shown to reduce and inhibit spheroid formation, colony formation, proliferation, and tumor formation abilities, as well as attenuate CD133, CD13, OCT-4, SOX2, and Nanog expression in LCSCs. Furthermore, downregulation of lncRNA DLX6-AS1 contributed to a reduction in CADM1 promoter methylation via suppression of DNMT1, DNMT3a, and DNMT3b in LCSCs and inactivating the STAT3 signaling pathway. CONCLUSION: This study demonstrated that down-regulated lncRNA DLX6-AS1 may inhibit the stem cell properties of LCSCs through upregulation of CADM1 by suppressing the methylation of the CADM1 promoter and inactivation of the STAT3 signaling pathway. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1239-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6554918
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65549182019-06-10 Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells Wu, Dong-Mei Zheng, Zi-Hui Zhang, Ying-Bo Fan, Shao-Hua Zhang, Zi-Feng Wang, Yong-Jian Zheng, Yuan-Lin Lu, Jun J Exp Clin Cancer Res Research BACKGROUND: Liver cancer stem cells (LCSCs) are a small subset of cells characterized by unlimited self-renewal, cell differentiation, and uncontrollable cellular growth. LCSCs are also resistant to conventional therapies and are thus believed to be held responsible for causing treatment failure of hepatocellular carcinoma (HCC). It has been recently found that long non-coding RNAs (lncRNAs) are important regulators in HCC. This present study aims to explore the underlying mechanism of how lncRNA DLX6-AS1 influences the development of LCSCs and HCC. METHODS: A microarray-based analysis was performed to initially screen differentially expressed lncRNAs associated with HCC. We then analyzed the lncRNA DLX6-AS1 levels as well as CADM1 promoter methylation. The mRNA and protein expression of CADM1, STAT3, CD133, CD13, OCT-4, SOX2, and Nanog were then detected. We quantified our results by evaluating the spheroid formation, proliferation, and tumor formation abilities, as well as the proportion of tumor stem cells, and the recruitment of DNA methyltransferase (DNMT) in LCSCs when lncRNA DLX6-AS1 was either overexpressed or silenced. RESULTS: LncRNA DLX6-AS1 was upregulated in HCC. The silencing of lncRNA DLX6-AS1 was shown to reduce and inhibit spheroid formation, colony formation, proliferation, and tumor formation abilities, as well as attenuate CD133, CD13, OCT-4, SOX2, and Nanog expression in LCSCs. Furthermore, downregulation of lncRNA DLX6-AS1 contributed to a reduction in CADM1 promoter methylation via suppression of DNMT1, DNMT3a, and DNMT3b in LCSCs and inactivating the STAT3 signaling pathway. CONCLUSION: This study demonstrated that down-regulated lncRNA DLX6-AS1 may inhibit the stem cell properties of LCSCs through upregulation of CADM1 by suppressing the methylation of the CADM1 promoter and inactivation of the STAT3 signaling pathway. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1239-3) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-06 /pmc/articles/PMC6554918/ /pubmed/31171015 http://dx.doi.org/10.1186/s13046-019-1239-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wu, Dong-Mei
Zheng, Zi-Hui
Zhang, Ying-Bo
Fan, Shao-Hua
Zhang, Zi-Feng
Wang, Yong-Jian
Zheng, Yuan-Lin
Lu, Jun
Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
title Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
title_full Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
title_fullStr Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
title_full_unstemmed Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
title_short Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
title_sort down-regulated lncrna dlx6-as1 inhibits tumorigenesis through stat3 signaling pathway by suppressing cadm1 promoter methylation in liver cancer stem cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554918/
https://www.ncbi.nlm.nih.gov/pubmed/31171015
http://dx.doi.org/10.1186/s13046-019-1239-3
work_keys_str_mv AT wudongmei downregulatedlncrnadlx6as1inhibitstumorigenesisthroughstat3signalingpathwaybysuppressingcadm1promotermethylationinlivercancerstemcells
AT zhengzihui downregulatedlncrnadlx6as1inhibitstumorigenesisthroughstat3signalingpathwaybysuppressingcadm1promotermethylationinlivercancerstemcells
AT zhangyingbo downregulatedlncrnadlx6as1inhibitstumorigenesisthroughstat3signalingpathwaybysuppressingcadm1promotermethylationinlivercancerstemcells
AT fanshaohua downregulatedlncrnadlx6as1inhibitstumorigenesisthroughstat3signalingpathwaybysuppressingcadm1promotermethylationinlivercancerstemcells
AT zhangzifeng downregulatedlncrnadlx6as1inhibitstumorigenesisthroughstat3signalingpathwaybysuppressingcadm1promotermethylationinlivercancerstemcells
AT wangyongjian downregulatedlncrnadlx6as1inhibitstumorigenesisthroughstat3signalingpathwaybysuppressingcadm1promotermethylationinlivercancerstemcells
AT zhengyuanlin downregulatedlncrnadlx6as1inhibitstumorigenesisthroughstat3signalingpathwaybysuppressingcadm1promotermethylationinlivercancerstemcells
AT lujun downregulatedlncrnadlx6as1inhibitstumorigenesisthroughstat3signalingpathwaybysuppressingcadm1promotermethylationinlivercancerstemcells